Artwork

Nội dung được cung cấp bởi Unusual Whales. Tất cả nội dung podcast bao gồm các tập, đồ họa và mô tả podcast đều được Unusual Whales hoặc đối tác nền tảng podcast của họ tải lên và cung cấp trực tiếp. Nếu bạn cho rằng ai đó đang sử dụng tác phẩm có bản quyền của bạn mà không có sự cho phép của bạn, bạn có thể làm theo quy trình được nêu ở đây https://vi.player.fm/legal.
Player FM - Ứng dụng Podcast
Chuyển sang chế độ ngoại tuyến với ứng dụng Player FM !

Unusual Whales Pod Ep. 43: GLP-1 Therapies for Obesity and Overall Health, Sponsored by Tema $HRTS ETF

1:22:17
 
Chia sẻ
 

Manage episode 441659162 series 3384473
Nội dung được cung cấp bởi Unusual Whales. Tất cả nội dung podcast bao gồm các tập, đồ họa và mô tả podcast đều được Unusual Whales hoặc đối tác nền tảng podcast của họ tải lên và cung cấp trực tiếp. Nếu bạn cho rằng ai đó đang sử dụng tác phẩm có bản quyền của bạn mà không có sự cho phép của bạn, bạn có thể làm theo quy trình được nêu ở đây https://vi.player.fm/legal.

Unusual Whales Pod Ep. 43: GLP-1 Therapies for Obesity and Overall Health, Sponsored by Tema $HRTS ETF

This episode of the Unusual Whales Pod was recorded Live on September 24th, 2024. Our host is joined by the CEO and CIO of Tema ETFs Maurits Pot and Yuri Khodjamirian, as well as medical and Biopharma experts to discuss the health landscape in regards to Obesity. A range of topics from GLP-1 treatment efficacy such as Ozempic and Wegovy, to the investor’s point of view and how to navigate the potentially volatile world of biopharma stocks. Via their actively managed GLP-1, Obesity & Cardiometabolic ETF, ticker $HRTS, Tema stays on top of developments in the field, and invests in what they say may be the biggest biopharma potential in the markets, right now.

Panel:

Maurits Pot https://x.com/mauritspot

Yuri Khodjamirian https://x.com/YuriKhodjam

Eric Feigl-Ding https://x.com/DrEricDing

Alexandra Sowa https://x.com/AlexandraSowaMD

BioPharmCatalyst https://twitter.com/BPharmCatalyst

Hosted by:

Nicholas FNS: https://twitter.com/NicholasFNS

Unusual Whales: https://twitter.com/unusual_whales

**

Disclaimer:

Any content referenced in the video or on Unusual Whales are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. You can lose some or all of your investment. See terms for more information.

  continue reading

46 tập

Artwork
iconChia sẻ
 
Manage episode 441659162 series 3384473
Nội dung được cung cấp bởi Unusual Whales. Tất cả nội dung podcast bao gồm các tập, đồ họa và mô tả podcast đều được Unusual Whales hoặc đối tác nền tảng podcast của họ tải lên và cung cấp trực tiếp. Nếu bạn cho rằng ai đó đang sử dụng tác phẩm có bản quyền của bạn mà không có sự cho phép của bạn, bạn có thể làm theo quy trình được nêu ở đây https://vi.player.fm/legal.

Unusual Whales Pod Ep. 43: GLP-1 Therapies for Obesity and Overall Health, Sponsored by Tema $HRTS ETF

This episode of the Unusual Whales Pod was recorded Live on September 24th, 2024. Our host is joined by the CEO and CIO of Tema ETFs Maurits Pot and Yuri Khodjamirian, as well as medical and Biopharma experts to discuss the health landscape in regards to Obesity. A range of topics from GLP-1 treatment efficacy such as Ozempic and Wegovy, to the investor’s point of view and how to navigate the potentially volatile world of biopharma stocks. Via their actively managed GLP-1, Obesity & Cardiometabolic ETF, ticker $HRTS, Tema stays on top of developments in the field, and invests in what they say may be the biggest biopharma potential in the markets, right now.

Panel:

Maurits Pot https://x.com/mauritspot

Yuri Khodjamirian https://x.com/YuriKhodjam

Eric Feigl-Ding https://x.com/DrEricDing

Alexandra Sowa https://x.com/AlexandraSowaMD

BioPharmCatalyst https://twitter.com/BPharmCatalyst

Hosted by:

Nicholas FNS: https://twitter.com/NicholasFNS

Unusual Whales: https://twitter.com/unusual_whales

**

Disclaimer:

Any content referenced in the video or on Unusual Whales are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. You can lose some or all of your investment. See terms for more information.

  continue reading

46 tập

Tất cả các tập

×
 
Loading …

Chào mừng bạn đến với Player FM!

Player FM đang quét trang web để tìm các podcast chất lượng cao cho bạn thưởng thức ngay bây giờ. Đây là ứng dụng podcast tốt nhất và hoạt động trên Android, iPhone và web. Đăng ký để đồng bộ các theo dõi trên tất cả thiết bị.

 

Hướng dẫn sử dụng nhanh